# Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia

> **NCT02217332** · PHASE2 · COMPLETED · sponsor: **Knopp Biosciences** · enrollment: 20 (actual)

## Conditions studied

- Chronic Sinusitis With Nasal Polyps and Eosinophilia

## Interventions

- **DRUG:** dexpramipexole

## Key facts

- **NCT ID:** NCT02217332
- **Lead sponsor:** Knopp Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-12-14
- **Final completion:** 2017-01-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02217332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02217332, "Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02217332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*